Ph 1 study of MRG-106, an inhibitor of miR-155, in CTCL
Autor: | Youn H. Kim, Herbert Eradat, Pierluigi Porcu, Christiane Querfeld, Jennifer DeSimone, Paul Rubin, Auris Huen, Lauren Pinter-Brown, Francine M. Foss, Gilad Gordon, Jud Williams, Linda A Pestano, Joan Guitart, Anita G. Seto, William Marshall, Diana Escolar, Basem M. William, Ahmad Halwani, Theresa R. Pacheco, Bradley M. Haverkos |
---|---|
Rok vydání: | 2018 |
Předmět: | |
Zdroj: | Journal of Clinical Oncology. 36:2511-2511 |
ISSN: | 1527-7755 0732-183X |
Popis: | 2511Background: MRG-106 is an inhibitor of miR-155, a microRNA with a strong link to CTCL pathogenesis. The goals of this FIH study are to evaluate the safety, tolerability, PK, and efficacy of MRG... |
Databáze: | OpenAIRE |
Externí odkaz: |